TY  - GEN
AU  - Raposeiras-Roubín, Sergio
AU  - Anguita, Manuel
AU  - Latini, Roberto
AU  - Domínguez-Rodríguez, Alberto
AU  - Barrabés, José A
AU  - Sánchez, Pedro L
AU  - Ottani, Filippo
AU  - Pocock, Stuart
AU  - Owen, Ruth
AU  - Cristobo, Pablo
AU  - Gómez-Talavera, Sandra
AU  - Staszewsky, Lidia
AU  - Escalera, Noemí
AU  - Fernández-Vázquez, Felipe
AU  - Bianco, Matteo
AU  - Prada-Delgado, Óscar
AU  - Pérez-García, Carlos Nicolás
AU  - Pelizzoni, Valentina
AU  - Navarro, Felipe
AU  - Pérez-Rivera, José-Ángel
AU  - Martín-Gorria, Gonzalo
AU  - Vetrano, Alfredo
AU  - Fuster, Valentín
AU  - Rosselló, Xavier
AU  - Ibáñez, Borja
PY  - 2026
UR  - https://hdl.handle.net/20.500.12105/27446
AB  - Recent trials have questioned the clinical benefit of beta-blockers in post-myocardial infarction (MI) patients with preserved left ventricular ejection fraction (LVEF). However, differences in pathophysiology and risk profile between MI with and...
LA  - eng
PB  - EDICIONES DOYMA
KW  - Acute coronary syndrome
KW  - Beta-blockers
KW  - Bloqueadores beta
KW  - Ensayo clínico aleatorizado
KW  - IAMCEST
KW  - IAMSEST
KW  - NSTEMI
KW  - Randomized controlled trial
KW  - STEMI
KW  - Síndrome coronario agudo
TI  - Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trial.
TY  - research article
ER  -